Search clinical trials for: AZD4785
Total 99 results
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid TumoursUnited States, United Kingdom
-
AstraZenecaQuotient SciencesCompleted
-
AstraZenecaCompletedSafety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and TmaxUnited Kingdom
-
AstraZenecaCompletedCarcinoma | Cancer | TumorsJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaTerminatedLymphomaUnited States, Canada
-
AstraZenecaTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
AstraZenecaCompleted
-
AstraZenecaTerminatedLymphoma | Non-Hodgkin Lymphoma | NHLUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaAstraZeneca K.K.RecruitingDyslipidemiaDenmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
-
Dizal PharmaceuticalsCompleted
-
AstraZenecaNational Institute of Mental Health (NIMH)CompletedTreatment Resistant Major Depressive DisorderUnited States
-
Dizal PharmaceuticalsRecruiting
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
AstraZenecaQuotient SciencesCompleted
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
AstraZenecaRecruitingCarcinoma, Non-Small-Cell Lung | Gastric Cancer | Gastroesophageal Junction CancerUnited States, Canada, Spain, China, Japan, France, Turkey, Netherlands, Moldova, Republic of, Georgia
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory Classical Hodgkin LymphomaItaly, United States, United Kingdom, Canada, Spain, France, Denmark
-
AstraZenecaWithdrawn
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
Dizal PharmaceuticalsCompleted
-
AstraZenecaCompleted
-
AstraZenecaParexelNot yet recruiting
-
NYU Langone HealthTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | MyelofibrosesUnited States
-
AstraZenecaParexelRecruiting
-
AstraZenecaParexelCompletedProgressive Metastatic Castrate-Resistant Prostate CancerUnited States, Spain, Belgium, France, Korea, Republic of
-
AstraZenecaCompletedMajor Depressive DisorderUnited States, South Africa, Chile, Slovakia
-
AstraZenecaCompletedOvarian Cancer | Locally Advanced Solid Tumours | Metastatic Solid TumoursUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
AstraZenecaTerminatedPreviously Treated Non Small Cell Lung CancerUnited States
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterTerminated
-
AstraZenecaParexelCompletedUterine Serous CarcinomaUnited States, Italy, Spain, France, Canada
-
Dana-Farber Cancer InstituteAstraZenecaActive, not recruitingUterine CancerUnited States
-
AstraZenecaQuintiles, Inc.CompletedSolid TumoursFrance, United Kingdom, Netherlands
-
Dizal PharmaceuticalsCompletedHealthy VolunteersUnited States
-
AstraZenecaTerminatedPreviously Untreated Stage IV Non-Squamous Non Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Completed
-
St. Joseph's Hospital and Medical Center, PhoenixBarbara Ann Karmanos Cancer Institute; American Society of Clinical Oncology; Translational Genomics Research Institute and other collaboratorsCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Locally Advanced Malignant Solid Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Locally Advanced Clear Cell Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States